Press Releases

Clinical Microbiology Market is Forecasted to Hit US$ 19.7 Bn By 2031 | CAGR 5.8%

The global Clinical Microbiology Market is projected to reach US$ 19.7 billion by 2031, expanding at a compound annual growth rate (CAGR) of 5.8% from

  • Date: 10 Sep, 2024
  • Author: Sagar Karlekar
Controlled Release Drug Delivery Market is Forecasted to Hit US$ 62.2 Bn By 2031 | CAGR 7.8%

Global Controlled Release Drug Delivery Market is expected to reach US$ 62.2 Bn in 2031 with a growth rate of 7.8%. The Controlled Release Drug D

  • Date: 05 Sep, 2024
  • Author: Sagar Karlekar
Critical Limb Ischemia Treatment Market is Forecasted to Hit US$ 5.4 Bn By 2031 | CAGR 6.7%

Global Critical Limb Ischemia Treatment Market is expected to reach US$ 5.4 Bn in 2031 with a growth rate of 6.7%. The Critical Limb Ischemia (CL

  • Date: 05 Sep, 2024
  • Author: Sagar Karlekar
Dental Anesthesia Market is Forecasted to Hit US$ 2.1 Bn By 2031 | CAGR 5.2%

The global dental anesthesia market is poised for significant growth, with projections indicating it will reach US$ 2.1 billion by 2031, expanding at

  • Date: 04 Sep, 2024
  • Author: Sagar Karlekar
Concierge Medicine Market Expected to Achieve US $35.9 Bn by 2031 | CAGR 6.9%

Global Concierge Medicine Market is expected to reach US$ 35.9 Bn in 2031 with a growth rate of 6.9%. Concierge medicine, a revolutionary approac

  • Date: 03 Sep, 2024
  • Author: Sagar Karlekar
Blood Brain Barrier Market is Forecasted to Hit US$ 1,231.4 Mn By 2031 | CAGR 11.3%

The Global Blood Brain Barrier (BBB) Market is projected to reach US$ 1,231.4 Mn by 2031, expanding at a compound annual growth rate (CAGR) of 11.3% d

  • Date: 27 Aug, 2024
  • Author: Sagar Karlekar
5-Hydroxytryptamine Receptor Market Expected to Achieve US $ 16.5 Bn by 2031 | CAGR 7.8%

Global 5-Hydroxytryptamine Receptor Market is expected to reach US$ 16.5 Bn in 2031 with a growth rate of 7.8%. The 5-Hydroxytryptamine (5-HT) Recepto

  • Date: 18 Jun, 2024
  • Author: Sagar Karlekar
Agrobacterium tumefaciens Competent Cells Market is Forecasted to Hit US$ 310 Mn By 2031 | CAGR 11.5%

The Agrobacterium tumefaciens Competent Cells Market is a niche segment within the broader biotechnology industry, catering to the needs of plant gene

  • Date: 18 Jun, 2024
  • Author: Sagar Karlekar
Adulticides Market is Forecasted to Hit US$ 14.4 Bn By 2031 | CAGR 8.4%

The Global Adulticides Market is projected to reach US$ 14.4 Bn by 2031, exhibiting a robust compound annual growth rate (CAGR) of 8.4% during the for

  • Date: 17 Jun, 2024
  • Author: Sagar Karlekar
Hot Flashes Market is Forecasted to Hit US$ 3.8 Bn By 2031 | CAGR 8.7%

The global hot flashes market, a segment of the healthcare industry focused on developing and providing treatment options for managing hot flashes exp

  • Date: 17 Jun, 2024
  • Author: Sagar Karlekar
Allergy Rhinitis Drug Market is Forecasted to Hit US$ 25.7 Bn By 2031 | CAGR 6.8%

The Allergy Rhinitis Drug Market, a crucial segment of the pharmaceutical industry, is poised for substantial growth in the coming years. This market

  • Date: 13 Jun, 2024
  • Author: Sagar Karlekar
Glucagon-Like Peptide 1 (GLP-1) Drugs Market Expected to Achieve US$ 18.2 Bn by 2031 | CAGR 12.1%

The Glucagon-Like Peptide 1 (GLP-1) Drugs Market falls under the pharmaceutical industry and focuses on the development, production, and commercializa

  • Date: 11 Jun, 2024
  • Author: Sagar Karlekar
Ambroxol Market is Forecasted to Hit US$ 720.1 Mn By 2031 | CAGR 5.2%

The Global Ambroxol Market is expected to reach US$ 720.1 Million in 2031 with a growth rate of 5.2%. Ambroxol is a mucolytic agent used to treat resp

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar
Aminoglycoside Antibiotics Market Expected to Achieve US$ 2.2 Bn by 2030 | CAGR 7.8%

The Global Aminoglycoside Antibiotics Market is expected to reach US$ 2.2 Bn by 2031, growing at a CAGR of 7.8% from 2024 to 2031.

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar
Aminophylline Market is Forecasted to Hit US$ 1.9 Bn By 2031 | CAGR 6.2%

The Global Aminophylline Market, a segment of the pharmaceutical industry, is projected to reach US$ 1.9 Bn by 2031, growing at a Compound Annual Grow

  • Date: 10 Jun, 2024
  • Author: Sagar Karlekar